hui zhuan Tan

Dr. hui zhuan Tan

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Kidney International
Verified
Journal Article
Closed access
HThui zhuan Tan
hui zhuan Tan
RTRu Yu Tan
Ru Yu Tan
JCJason Chon Jun Choo
Jason Chon Jun Choo
CLCynthia Ciwei Lim
Cynthia Ciwei Lim
CTChieh Suai Tan
Chieh Suai Tan
KWKeng Thye Woo
Keng Thye Woo

21 April 2017 in Nephrology
Verified
Journal Article
Closed access
PDF file
CLCynthia C Lim
Cynthia C Lim
PLPei Yun Liu
Pei Yun Liu
HThui zhuan Tan
hui zhuan Tan
PLPeishan Lee
Peishan Lee
YCYok Mooi Chin
Yok Mooi Chin
JCJason Cj Choo
Jason Cj Choo

10 February 2020 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
CLCynthia Ciwei Lim
Cynthia Ciwei Lim
HThui zhuan Tan
hui zhuan Tan
CTChieh Suai Tan
Chieh Suai Tan
HHHelen Healy
Helen Healy
JCJason Choo
Jason Choo
PGPedro Henrique Franca Gois
Pedro Henrique Franca Gois

30 June 2021 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
CLCynthia C. Lim
Cynthia C. Lim
JCJason C. J. Choo
Jason C. J. Choo
HThui zhuan Tan
hui zhuan Tan
IMIrene Y. J. Mok
Irene Y. J. Mok
YCYok Mooi Chin
Yok Mooi Chin
KWKeng Thye Woo
Keng Thye Woo
Cardiovascular disease causes significant morbidity and mortality in patients with glomerulonephritis, which is increasingly diagnosed in older individuals who may have diabetes mellitus (DM). We evaluated the impact of DM on metabolic profile, renal and cardiovascular outcomes during treatment and follow-up of individuals with glomerulonephritis. We performed a retrospective cohort study of 601 consecutive adults with biopsy-proven glomerulonephritis for factors associated with kidney failure, hospitalization for cardiovascular events, and death. Biopsies with isolated diabetic nephropathy were excluded. The median patient age was 49.8 years (36.7-60.9 years) with estimated glomerular filtration rate of 56.7 mL/min/1.73 m2 (27.7-93.2 mL/min/1.73 m2). DM was present in 25.4%. The most frequent diagnoses were minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS) (29.5%), lupus nephritis (21.3%), immunoglobulin A (IgA) nephropathy (19.1%), and membranous nephropathy (12.1%). The median follow-up was 38.8 months (interquartile range [IQR], 26.8-55.8 months). Among 511 individuals with lupus nephritis, anti-neutrophil cytoplasmic antibody-associated vasculitis, MCD/FSGS, membranous nephropathy, and IgA nephropathy, 52 (10.2%) developed kidney failure at a median 16.4 months (IQR, 2.3-32.2 months), while 29 (5.7%) had cardiovascular-related hospitalizations at 12.9 months (IQR, 4.8-31.8 months) and 31 (6.1%) died at 13.5 months (IQR, 2.5-42.9 months) after diagnosis. Cox regression analysis found that baseline DM was independently associated with kidney failure (adjusted hazard ratio [HR], 2.07; 95% confidence interval [CI], 1.06-4.05, p = 0.03) and cardiovascular-related hospitalization (adjusted HR, 2.69; 95% CI, 1.21-5.98, p = 0.02) but not with mortality. DM was strongly associated with kidney failure and hospitalization for cardiovascular events in patients with biopsy-proven glomerulonephritis.

4 September 2018 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
CLCynthia C. Lim
Cynthia C. Lim
HThui zhuan Tan
hui zhuan Tan
YHYing Hao
Ying Hao
YCYok Mooi Chin
Yok Mooi Chin
KWKeng Thye Woo
Keng Thye Woo
JCJason C. J. Choo
Jason C. J. Choo

9 April 2018 in Lupus
Verified
Journal Article
Closed access
PLP Liu
P Liu
HThui zhuan Tan
hui zhuan Tan
HLH Li
H Li
CLC C Lim
C C Lim
JCJ C J Choo
J C J Choo
Background: There are limited studies documenting infection epidemiology in lupus nephritis (LN) patients. We aimed to study infection incidences and risk characteristics and ascertain possible predictors of infective outcomes in a multiethnic Asian population. Methods: This retrospective study from 2006 to 2012 included newly diagnosed LN patients. We collected admissions, immunosuppression, and infection data until end-stage renal failure, death, last follow-up, or the year 2015. The infection incidence rates were evaluated and a generalized linear latent and mixed models (GLLAMM) analysis was carried out to evaluate potential predictors of infection. Results: Our cohort of 101 patients consisted of mainly Chinese (75.2%), females (78.2%), and a median age of 38 years (IQR 26–49). The median time of follow-up was 72.8 months (IQR 49.5–94.0). Six out of 14 patient deaths were infection related. Seventy-eight out of 200 admissions, with a total of 102 episodes of infection, occurred in 46 patients. The incidence of infection rates leading to admissions was 10.3 per 100 person-years and the incidence of infection episodes rates was 17.6 per 100 person-years. Cytomegalovirus (CMV) was the most common organism identified. Univariate GLLAMM analysis showed Malay compared to Chinese ethnicity (HR 2.833 (95% CI 1.088–7.373)), use of oral cyclophosphamide (HR 6.618 (95% CI 1.015–43.154)) and rituximab (HR 3.967 (95% CI 1.157–13.603)) as predictors of infection-related admissions. Malay ethnicity and rituximab remained significant in the multivariate GLLAMM analysis. Conclusions: Our study highlights substantial infection incidences in patients with LN and its contribution to deaths.